# Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer

> **NCT00002846** · PHASE2 · UNKNOWN · sponsor: **Blumenthal Cancer Center at Carolinas Medical Center** · enrollment: 14 (estimated)

## Conditions studied

- Kidney Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00002846
- **Lead sponsor:** Blumenthal Cancer Center at Carolinas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1995-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002846, "Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00002846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*